Zerodol Spas Tablet is a combination medication containing Drotaverine 80 mg and Aceclofenac 100 mg, formulated to provide effective relief from pain associated with smooth muscle spasms and inflammatory conditions. Drotaverine, an antispasmodic agent, acts by inhibiting phosphodiesterase-IV, leading to relaxation of smooth muscles without affecting normal muscle tone, thereby alleviating spasmodic pain commonly seen in gastrointestinal, genitourinary, and biliary tract disorders. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts analgesic, anti-inflammatory, and antipyretic effects by selectively inhibiting cyclooxygenase-2 (COX-2), reducing the synthesis of prostaglandins responsible for pain and inflammation. The synergistic action of these two components makes Zerodol Spas effective in managing conditions such as renal colic, biliary colic, dysmenorrhea, musculoskeletal pain, and postoperative pain where muscle spasm and inflammation coexist. It is generally well tolerated but should be used with caution in patients with a history of gastrointestinal ulcers, cardiovascular disorders, or renal impairment. Zerodol Spas should be administered under medical supervision, adhering to prescribed dosages to minimize potential adverse effects such as gastrointestinal discomfort, hypersensitivity reactions, or elevated liver enzymes. This combination offers a comprehensive approach to pain management by targeting both muscle spasm and inflammatory pathways.